The U.S. Department of Defense (DOD) Defense Logistics Agency (DLA) awarded a $14,048.42 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 4566803438 - RINVOQ ER 15 MG TABLET UU 30S. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a comprehensive vehicle for supplying a range of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a $26,515.61 firm-fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of RINVOQ ER 30 MG TABLET UU 30S. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical and medical supplies to military treatment facilities worldwide. The contract does not have a set-aside designation. AmerisourceBergen, a major...
The Defense Logistics Agency (DLA) has awarded a $8,241.24 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office Division to provide 4564530227 RINVOQ ER 15 MG TABLET UU 30S. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical to deliver a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense (DoD)...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $10,640.94 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of RINVOQ ER 15 MG TABLET, a specialty medication, to support government healthcare programs. This award is part of AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for providing a wide range of...
This is a $49,941.35 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RINVOQ ER 15 MG TABLET. The contract has an ultimate completion date of August 6, 2024 and is not set aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a comprehensive range of medical...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of RINVOQ ER 45 MG TABLET for a ceiling value of $48,405.36. The contract has an ultimate completion date of October 10, 2024 and is a firm fixed-price contract. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that has been awarded numerous contracts by federal agencies, including the DLA and the Department of Justice Federal Bureau of Investigation, to...
The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order worth $6,942.03 to AmerisourceBergen Drug Corp for the supply of RINVOQ ER 15 MG TABLET UU 30S. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for delivering a wide range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The contract has no set-aside designation...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $7,074.07 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of RINVOQ ER 30 MG TABLET UU 30S. This order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA Troop Support Medical, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
The U.S. Defense Logistics Agency (DLA) awarded a $23,436.74 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division for the supply of RINVOQ ER 15 MG TABLET pharmaceutical products. This award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for providing a comprehensive range of medical commodities to support military treatment programs and facilities...
The Defense Logistics Agency (DLA) awarded a $69,691.00 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, for the supply of RINVOQ ER 45 MG TABLET UU 28S. This is a delivery order issued under an existing Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 through December 2025 for the provision of a comprehensive range...